BrightSpring Health Services (NASDAQ:BTSG) Posts Earnings Results, Beats Estimates By $0.10 EPS

BrightSpring Health Services (NASDAQ:BTSG) announced its quarterly earnings data on Friday. The company reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.10, Briefing.com reports. BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The company had revenue of $3.61 billion during the quarter, compared to analysts’ expectations of $3.39 billion. During the same quarter in the prior year, the company posted $0.14 EPS. The business’s revenue was up 25.6% on a year-over-year basis.

Here are the key takeaways from BrightSpring Health Services’ conference call:

• Q1 financials — Total revenue was $3.6 billion (+26% YoY) with adjusted EBITDA of $190 million (+45% YoY) and a 5.3% adjusted EBITDA margin (up ~70 bps); operating cash flow was $123 million.
• Pharmacy solutions momentum — Specialty & infusion revenue was $2.6 billion (+36% YoY) with ~30% specialty script growth, four new exclusive/ultra-narrow LDDs added (total 153 LDDs), double?digit infusion growth and new concierge programs like IG Connect.
• Provider services growth & quality — Provider revenue of $442 million (+28% YoY) included home health at $266 million (+49%), with acquired branches contributing ~$79 million of revenue and ~$9 million of adjusted EBITDA in Q1; quality metrics (91% of branches 4+ stars, >99% timely initiation) remain strong.
• Regulatory and conversion headwinds — Home & community pharmacy revenue declined 9% in Q1; management expects ~ $175M full?year IRA impact to that business and previously cited roughly $181M (IRA specialty) plus ~$250M of brand?to?generic pressure (~$600M total headwind), with a $15M EBITDA mitigation unchanged.
• Balance sheet & guidance — Sold community living for ~$811M (pre?tax) to strengthen the balance sheet, reducing leverage to 2.27x (pro forma 2.40x); 2026 guidance (ex?community living) targets $14.725B–$15.225B revenue and $795M–$825M adjusted EBITDA, which includes ~ $30M expected contribution from acquired Amedisys/LHC assets.

BrightSpring Health Services Stock Up 9.6%

Shares of NASDAQ BTSG opened at $52.58 on Friday. The firm has a market capitalization of $10.16 billion, a PE ratio of 37.29, a price-to-earnings-growth ratio of 0.74 and a beta of 1.72. The company has a current ratio of 1.57, a quick ratio of 1.12 and a debt-to-equity ratio of 1.32. BrightSpring Health Services has a 1 year low of $19.01 and a 1 year high of $54.68. The firm’s 50-day moving average is $43.50 and its 200-day moving average is $38.79.

More BrightSpring Health Services News

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Q1 results beat street estimates — EPS of $0.39 topped consensus (~$0.32) and revenue of $3.61B beat estimates (~$3.39B); revenue was up ~25.6% year?over?year, signaling healthy top?line growth. Quarterly results and call
• Positive Sentiment: Company raised full?year 2026 revenue and adjusted EBITDA guidance (management increased its FY revenue range to roughly $14.7B–$15.2B), which supports the rally and suggests management confidence in demand and margins. BrightSpring extends rally with upgraded forecast
• Positive Sentiment: Street recognition — BTSG was added to Zacks’ top growth (Rank #1) list, which can support additional retail/institutional interest. Zacks Rank #1 inclusion
• Neutral Sentiment: Investor materials available — management hosted a call and posted a press release and slide deck with more detail on results and guidance for investors to evaluate execution and forward assumptions. Press release and slides
• Negative Sentiment: Valuation and leverage remain considerations — BTSG trades at a high P/E (~60) with a beta >2 and debt/equity ~1.32; strong results improve the story but raise expectations that the company must sustain growth to justify the valuation.

Analysts Set New Price Targets

Several equities research analysts have weighed in on BTSG shares. Wells Fargo & Company raised their price objective on shares of BrightSpring Health Services from $43.00 to $50.00 and gave the company an “overweight” rating in a research report on Monday, March 2nd. Leerink Partners restated an “outperform” rating and issued a $49.00 price objective on shares of BrightSpring Health Services in a research report on Wednesday, March 18th. Mizuho raised their price objective on shares of BrightSpring Health Services from $50.00 to $52.00 and gave the company an “outperform” rating in a research report on Wednesday, March 18th. Zacks Research upgraded shares of BrightSpring Health Services from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, March 3rd. Finally, BMO Capital Markets restated an “outperform” rating and issued a $60.00 price objective on shares of BrightSpring Health Services in a research report on Friday. Two research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $46.50.

Insider Activity

In other news, CFO Jennifer A. Phipps sold 35,000 shares of the firm’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total value of $1,440,250.00. Following the transaction, the chief financial officer owned 196,840 shares of the company’s stock, valued at approximately $8,099,966. This trade represents a 15.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jon B. Rousseau sold 220,000 shares of BrightSpring Health Services stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total transaction of $9,053,000.00. Following the transaction, the insider directly owned 1,023,880 shares in the company, valued at $42,132,662. The trade was a 17.69% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 285,000 shares of company stock valued at $11,727,750. 2.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. T. Rowe Price Investment Management Inc. boosted its stake in BrightSpring Health Services by 21.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,123,865 shares of the company’s stock worth $229,339,000 after acquiring an additional 1,091,757 shares during the last quarter. Invesco Ltd. boosted its stake in BrightSpring Health Services by 13.4% during the 4th quarter. Invesco Ltd. now owns 10,595,232 shares of the company’s stock worth $396,791,000 after acquiring an additional 1,248,107 shares during the last quarter. Virtue Capital Management LLC boosted its stake in BrightSpring Health Services by 45.9% during the 4th quarter. Virtue Capital Management LLC now owns 32,984 shares of the company’s stock worth $1,267,000 after acquiring an additional 10,371 shares during the last quarter. State of Tennessee Department of Treasury bought a new position in BrightSpring Health Services during the 4th quarter worth approximately $1,915,000. Finally, Mackenzie Financial Corp bought a new position in BrightSpring Health Services during the 4th quarter worth approximately $252,000.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.